What is the purpose of this trial?
The study is performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care
Ages: 18 years and older
Gender: Female only
Bayer Healthcare Pharmaceuticals, Inc.
Start Date: 04/18/2018
End Date: 12/31/2018
Last Updated: 06/20/2018
Study HIC#: 2000021011